Insider: Deschatelets Pascal Chief Scientific Officer - Apellis Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,147,716 | 0 | 1,147,716 |
| Value | $25,674,406.92 | $0.00 | $25,674,406.92 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/29/2025 | DDS | 826 | Direct | COM | $29.52 | $24,386.49 | 1,147,716 |
| 01/22/2025 | DDS | 3,948 | Direct | COM | $30.43 | $120,119.87 | 1,148,542 |
| 01/17/2025 | DDS | 750 | Direct | COM | $29.96 | $22,468.65 | 1,137,445 |
| 01/13/2025 | DDS | 2,288 | Direct | COM | $28.70 | $65,670.40 | 1,138,195 |
| 05/08/2024 | DDS | 56,335 | Direct | COM | $42.15 | $2,374,542.78 | 1,138,555 |
| 05/08/2024 | DDS | 100 | Direct | COM | $44.03 | $4,402.50 | 1,115,983 |
| 05/08/2024 | DDS | 22,472 | Direct | COM | $42.85 | $962,902.73 | 1,116,083 |
| 04/08/2024 | DDS | 64,379 | Direct | COM | $54.12 | $3,483,966.15 | 1,120,711 |
| 04/08/2024 | DDS | 4,728 | Direct | COM | $54.92 | $259,639.07 | 1,115,983 |
| 03/08/2024 | DDS | 42,750 | Direct | COM | $61.88 | $2,645,173.35 | 1,142,340 |
| 03/08/2024 | DDS | 26,257 | Direct | COM | $62.69 | $1,646,040.83 | 1,116,083 |
| 03/08/2024 | DDS | 100 | Direct | COM | $63.35 | $6,335.00 | 1,115,983 |
| 02/12/2024 | DDS | 1,148 | Direct | COM | $67.77 | $77,796.40 | 1,115,983 |
| 01/29/2024 | DDS | 874 | Direct | COM | $64.14 | $56,056.79 | 1,117,131 |
| 01/22/2024 | DDS | 3,913 | Direct | COM | $65.00 | $254,329.35 | 1,118,005 |
| 01/16/2024 | DDS | 1,632 | Direct | COM | $66.81 | $109,031.64 | 1,121,918 |
| 11/08/2023 | DDS | 12,000 | Direct | COM | $47.27 | $567,240.00 | 1,071,807 |
| 10/09/2023 | DDS | 12,000 | Direct | COM | $40.38 | $484,560.00 | 1,066,313 |
| 09/08/2023 | DDS | 12,000 | Direct | COM | $42.87 | $514,440.00 | 1,059,813 |
| 08/08/2023 | DDS | 12,000 | Direct | COM | $23.66 | $283,920.00 | 1,053,313 |
| 07/10/2023 | DDS | 12,000 | Direct | COM | $84.55 | $1,014,600.00 | 1,046,813 |
| 06/08/2023 | DDS | 12,000 | Direct | COM | $91.35 | $1,096,200.00 | 1,040,313 |
| 05/08/2023 | DDS | 12,000 | Direct | COM | $92.39 | $1,108,680.00 | 1,033,813 |
| 04/10/2023 | DDS | 12,000 | Direct | COM | $78.21 | $938,520.00 | 1,027,313 |
| 03/08/2023 | DDS | 12,000 | Direct | COM | $63.79 | $765,480.00 | 1,020,813 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research